• No results found

 NOVEL, SUSTAINED-RELEASE, DRY-POWDER INHALABLE FORMULATION FOR MONTELUKAST SODIUM

N/A
N/A
Protected

Academic year: 2020

Share " NOVEL, SUSTAINED-RELEASE, DRY-POWDER INHALABLE FORMULATION FOR MONTELUKAST SODIUM"

Copied!
7
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Table 1: Formulation of Montelukast sodium, Eudragit RS 100 microparticles
Figure 5:  Fourier Transform Infrared Spectra graph of Trial D

References

Related documents

An English translation (accuracy confirmed by back translation) of the two ques- tionnaires on personal preference is shown in Table 1. Similar statements with appropriate

ITACA, working together with the Italian Hereditary Angioedema Patients ’ Association, col- lected data from C1-INH-HAE patients referring to 17 centers active in Italy.. Here

To investigate whether the EGFR receptor enhanced cellular uptake of DOX@PLGA/PD-C nanoparticles and photothermal effect of the nanoparticle can be translated into

litz NJ, Dow JAT: Neuropeptide stimulation of the nitric oxide signaling pathway in Drosophila melanogaster Malpighian tubules. O'Donnell MJ, Rheault MR, Davies SA, Rosay P,

In comparison with the results of the standard shoe during stair walking, the peak knee adduction angle reduced by 10.0%, 8.7% and 8.7% during stair ascent and by 9.0%, 6.7% and

This study aims to develop arduino- based experimental equipment in investigating the constant inertia of rigid ball and cylinder which roll on a sloping

Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Bilimoria